p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis
Cancer Cell International（2024）
关键词
SH003,Docetaxel,Combination treatment,Non-small cell lung cancer,Pyrimidine biosynthesis,TP53,Biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要